BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 33637109)

  • 21. Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study.
    Brcic L; Klikovits T; Megyesfalvi Z; Mosleh B; Sinn K; Hritcu R; Laszlo V; Cufer T; Rozman A; Kern I; Mohorcic K; Jakopovic M; Samarzija M; Seiwerth S; Kolek V; Fischer O; Jakubec P; Škarda J; Gieszer B; Hegedus B; Fillinger J; Renyi-Vamos F; Buder A; Bilecz A; Berger W; Grusch M; Hoetzenecker K; Klepetko W; Hoda MA; Filipits M; Dome B
    Transl Lung Cancer Res; 2021 Apr; 10(4):1594-1607. PubMed ID: 34012777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology.
    Swati ; Sharma V
    Mol Biol Rep; 2022 Nov; 49(11):10825-10847. PubMed ID: 35871482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
    Franzen A; Bootz F; Dietrich D
    HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma.
    Šutić M; Baranašić J; Bilić LK; Bilić M; Jakovčević A; Brčić L; Seiwerth S; Jakopović M; Samaržija M; Zechner U; Knežević J
    Diagn Pathol; 2021 Feb; 16(1):17. PubMed ID: 33637109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.
    Lleras RA; Smith RV; Adrien LR; Schlecht NF; Burk RD; Harris TM; Childs G; Prystowsky MB; Belbin TJ
    Clin Cancer Res; 2013 Oct; 19(19):5444-55. PubMed ID: 23894057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
    Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
    Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter methylation status of
    Šutić M; Motzek A; Bubanović G; Linke M; Sabol I; Vugrek O; Ozretić P; Brčić L; Seiwerth S; Debeljak Ž; Jakovčević A; Janevski Z; Stančić-Rokotov D; Vukić-Dugac A; Jakopović M; Samaržija M; Zechner U; Knežević J
    Transl Lung Cancer Res; 2019 Dec; 8(6):1000-1015. PubMed ID: 32010578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.
    Jurmeister P; Bockmayr M; Seegerer P; Bockmayr T; Treue D; Montavon G; Vollbrecht C; Arnold A; Teichmann D; Bressem K; Schüller U; von Laffert M; Müller KR; Capper D; Klauschen F
    Sci Transl Med; 2019 Sep; 11(509):. PubMed ID: 31511427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Daher T; Tur MK; Brobeil A; Etschmann B; Witte B; Engenhart-Cabillic R; Krombach G; Blau W; Grimminger F; Seeger W; Klussmann JP; Bräuninger A; Gattenlöhner S
    Head Neck; 2018 Jun; 40(6):1109-1119. PubMed ID: 29522268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.
    Kottaridi C; Koureas N; Margari N; Terzakis E; Bilirakis E; Pappas A; Chrelias C; Spathis A; Aga E; Pouliakis A; Panayiotides I; Karakitsos P
    Biomed Res Int; 2015; 2015():756359. PubMed ID: 26504828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Previous head and neck cancers portend poor prognoses in lung cancer patients.
    Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
    Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
    Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
    Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
    J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.